Market Research Future published new report, titled “Pharmaceutical Grade Lactose Market -Research Report: Global Forecast to 2023”.
The Global Pharmaceutical grade lactose Market is a specialized grade of lactose that meets the rigid pharmaceutical expectations. It is produced by concentrating whey or permeate to over-saturate the lactose, which is then further refined, dried, and milled properly. Pharmaceutical grade lactose is manufactured in different specialty and customized range to use in various oral solid dosage forms (OSDFs) such as tablets, capsules, sachets, dry powder inhalers and others.
In solid form, lactose can either be in an amorphous state or in a crystalline state. The most well-known forms of crystalline lactose are α-lactose monohydrate and β-lactose. Crystallinity of lactose particles is the result of high ordered arrangement of lactose molecules. Α-lactose monohydrate is produced by crystallization of highly concentrated lactose solutions at low temperatures, which is then separated from the mother liquor and dried off. Α-lactose is mainly used as an excipient in the production of solid dosage forms through wet granulation and direct compression processes.
Notably increasing approval from government bodies to use pharmaceutical grade lactose as an excipient is the key factor driving the pharmaceutical grade lactose market. According to the 2017 updated inactive ingredient database by FDA, lactose is approved to be used as an excipient for different dosage forms. Many pharmaceutical grade lactose are also included in medicines licensed in the U.K such as, lactose powder manufactured by LFA tablet presses. Due to broad availability and cost effectiveness, lactose is getting great acceptance across the world.
Other factors such as, drug formulation coupled with nanotechnology, efficient compatibility with active ingredients and other excipients, and increasing demand for dry powder inhalers (DPI) products will boost the growth of the market. The advantage of using pharmaceutical grade lactose for DPI products is its low price and broad availability. There are many other drugs in the market for which lactose is used as excipient such as, Alprazolam; in which lactose monohydrate is present as an inactive ingredient. According to the Journal of Thermal Analysis and Calorimetry (2015), lactose is also used as an inactive ingredient in Estradiol drug
However, lactose-induced health complications, stringent government regulations, and lack of compatibility of pharmaceutical grade lactose with amine based drugs may hinder the growth of the market. According to a study published in the Revista Mexicana de Ciencias (Mexican Journal of Sciences) in 2015, lactose has propensity to react with primary and secondary amine drugs through Maillard reaction to produce colored products.
Key Players for Pharmaceutical Grade Lactose Market:
Some of key the players in the market are BASF SE, Merck KGaA, Kerry Inc. DFE Pharma, Meggle, Armor Pharma, ALPAVIT and others.
On the basis of regions, the pharmaceutical grade lactose market is segmented into Europe, Asia Pacific, America, and the Middle East & Africa.
Europe has accounted for the major share of the market. Increasing demand for dry powder inhaler (DPI) products, and rising approval from government bodies are the key drivers for the growth of the market in Europe. Moreover, increasing healthcare expenditure, and rising R&D activities, also supporting the market growth.
Asia Pacific accounts for the second largest and fastest growing pharmaceutical grade lactose market owing to the improving health infrastructure, and developing pharmaceutical industry. According to the Indian Brand Equity Foundation (IBEF), in 2016 the generics market of India stood at USD 26.1 billion. Asia Pacific consists of regions namely Japan, China, India, Australia, Republic of Korea, and rest of Asia Pacific.
Pharmaceutical grade lactose market growth in the Americas is majorly attributed to the approval for the usage of lactose as excipient by FDA. However, high occurrence of lactose induced problems has strongly affected the growth of the market.
The Middle East and Africa holds the least share in the market owing to the presence of poor and slow developing countries, especially, in African region.
The pharmaceutical grade lactose market is segmented on the basis of type, and application. On the basis of type, the market is segmented into crystalline monohydrate lactose, inhalation lactose, granulated lactose, spray dried lactose, and others. Crystalline monohydrate lactose is further segmented into α-Lactose monohydrate, and β-Lactose (anhydrous lactose). Sub-segmentation of α-Lactose monohydrate includes milled, and sieved. Inhalation lactose is further segmented into sieved, and milled. On the basis of application, the market is classified into tablets manufacturing, capsule manufacturing, and others. Tablets manufacturing is further classified into direct compression, wet granulation, and dry granulation. Capsule manufacturing is further classified into capsules, sachets, and others.
GET SAMPLE REPORT @ https://www.marketresearchfuture.com/sample_request/4816 .
Table of Contents:
1 Report Prologue
2 Market Introduction
2.1 Introduction 12
2.2 Scope Of The Study 12
2.2.1 Research Objective 12
2.2.2 Assumptions 12
2.2.3 Limitations 13
2.3 Market Structure 13
3 Research Methodology
3.1 Primary Research Methodology 15
3.2 Secondary Research Methodology 17
3.3 Market Share Analysis 18
3.4 Trade Analysis 18
3.5 Market Pricing Approach 18
4 Market Dynamics
4.1 Introduction 19
4.2 Drivers 20
4.2.1 Increasing Demand For Dry Powder Inhalers (DPI) Products
(Impact Weightage: 30%) 20
4.2.2 Compatibility With Active Ingredients And Other Excipients
(Impact Weightage: 15%) 21
4.2.3 Approval From Government Bodies (Impact Weightage: 25%) 22
4.2.4 Drug Formulation Coupled With Nanotechnology Will Boost The Growth Of Pharmaceutical Grade Lactose Market (Impact Weightage: 30%) 23
4.3 Restrains 24
4.3.1 Lactose-Induced Problems (Impact Weightage: 40%) 24
4.3.2 Stringent Government Regulations (Impact Weightage: 30%) 25
4.3.3 Lack Compatibility With Amine Based Drugs (Impact Weightage: 30%) 26
4.4 Opportunity 27
4.5 Mega Trends 27
4.5.1 Using Lactose As Excipient In Nanotechnology-Based Drug Formulations 27
4.6 Macroeconomic Indicators 27
4.7 Technology Trends & Assessment 28
5 Market Factor Analysis
5.1 Value Chain Analysis 29
5.1.1 R&D 29
5.1.2 Manufacturing 29
5.1.3 Distribution & Sales 30
5.1.4 Post-Sales Monitoring 30
5.2 Porters Five Forces Model 31
5.2.1 Bargaining Power Of Suppliers (Medium To High) 32
5.2.2 Bargaining Power Of Buyers (Low To Medium) 32
5.2.3 Threat Of New Entrants (Low To Medium) 32
5.2.4 Threat Of Substitutes (High) 32
5.2.5 Intensity Of Rivalry (Medium) 32
5.3 Demand & Supply: Gap Analysis 33
5.3.1 Pricing Analysis 33
5.3.2 Investment Opportunity Analysis 33
GET DISCOUNT @ https://www.marketresearchfuture.com/check-discount/4816.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
Company Name: Market Research Future
Contact Person: Akash Anand
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune –